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Abstract 
Increasing energy demand has spurred interest in the use of biofuels. Jatropha curcas (physic nut), an inedible oilseed, 
is a potential source of bioenergy. The seeds, however, contain allergens such as Jat c 1, a 2S albumin that can induce 
hypersensitivity reactions in humans and result in allergic diseases. Recent advances in identifying and characterizing 
plant allergens and, in particular, their immunoglobulin E (IgE)-binding epitopes have produced a wealth of informa-
tion. We identified IgE-binding regions and the critical amino acids involved in the degranulation of mast cells and 
the release of histamine, preliminary steps for the prevention and treatment of this allergy. Four IgE-binding regions 
were identified in the sequence of Jat c 1. We identified and demonstrated the fundamental role of two glutamic acid 
residues in IgE binding. The sequence LEKQLEEGEVGS produces a random loop on the most exposed part of Jat c 1. 
This region is important to the stimulation of the allergic response. The possibility of using this information to produce 
vaccines and other pharmacological agents for allergy treatment is discussed.
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Background
The increasing demand for food and fuel as lifestyle 
expectations rise in a population expected to reach 
nine billion by 2050 will soon become global challenges 
(Cohen et al. 2005; Lutz and Samir 2010). Food and fuel 
security are inextricably linked. Indeed, the competi-
tion between the use of oilseeds as biodiesel and food is 
increasing. Inedible oilseeds, such as those that contain 
toxins and allergens, may thus represent an ideal choice 
of feedstock for the biofuel industry.
Jatropha curcas is an oleaginous plant able to grow 
under various agroclimatic conditions and on land with 
thin soil cover (Devappa et  al. 2010, 2011). It is widely 
grown in Mexico, Nicaragua, northeastern Thailand 
and in parts of India and is being promoted in southern 
Africa, Brazil, Mali and Nepal. Several governments, 
international organizations and national bodies are pro-
moting the planting and use of J. curcas and other oil-
bearing plants as biofuels (Openshaw 2000; Makkar et al. 
2009). Studies are being developed to maximizing the 
production of biofuel with the direct use of the J. curcas 
oil (Go et al. 2016). J. curcas is superficially a promising 
oilseed because of its high oil content and its inedibility, 
due to its high toxicity (Makkar et  al. 2009). The toxic 
genotype is prevalent throughout the world and the non-
toxic genotypes exist only to the Mexico that is geneti-
cally differentiated (Massimo et  al. 2015). This varieties 
genetically improved are being investigated by the tech-
nology of DNA-based molecular markers (Chavan and 
Gaur 2015). These toxic and allergenic factors (Maciel 
et al. 2009), however, have also limited its use in biofuel 
production, because the toxins restrict the use of the 
cake, and the allergens compromise the safe handling of 
the seeds.
The elucidation of the primary and three-dimensional 
structures of allergens, including the identification of 
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regions involved in allergic reactions, such as IgE-bind-
ing, B cell and T-cell epitopes, is critical to the under-
standing of the allergic mechanisms elicited by these 
proteins and the possible cross-reactions between differ-
ent allergens. Such identification allows the development 
of a panel of allergenic epitopes, identifying the common 
aspects among these epitopes, and can direct the devel-
opment of specific immunotherapies that are effective 
against a group of cross-allergens. Vaccines based on 
epitopes may thus avoid some of the problems with the 
vaccines developed from plant extracts or from whole 
proteins. Jat c 1, which cross-reacts with the Ricinus com-
munis allergen, is the only allergenic protein yet isolated 
from J. curcas seeds (Maciel et  al. 2009). Maciel et  al. 
(2009), however, only described the N-terminus of Jat c 1, 
which prevented the elucidation of its allergenic epitopes.
We have thus purified and fully characterized Jat c 1, 
identified regions involved in allergenic response and 
searched for homologous IgE-binding epitopes in aller-
genic proteins from other plants. The results presented 
herein increase the information available for this J. curcas 
allergen and may contribute to future efforts at develop-
ing immunotherapeutic and allergen-inactivation strat-
egies to ensure that its oil extraction is safe for biofuel 
production.
Methods
Investigation of sequencial IgE‑binding epitopes: 
denaturation, reduction and alkylation
Jatropha curcas seeds were obtained from EMBRAPA 
(Empresa Brasileira de Pesquisa Agropecuária), Brazil, 
and Jat c 1 was isolated and identified by SDS-PAGE and 
immunoblotting as described by Maciel et al. (2009). The 
molecular weight of the isolated protein was determined 
by mass spectrometry using a Synapt G2SI Waters spec-
trometer. Jat c 1 was denatured with 6  M guanidinium 
chloride, reduced with 2 mM dithiothreitol and alkylated 
with 4-vinylpyridine (560  μmol), as described by Felix 
et  al. (2008), for investigating the presence of continu-
ous epitopes. The reaction mixture was submitted to C18 
reverse-phase HPLC for S- and L-chain separation. The 
chromatograph had a flow rate of 0.7  mL  min−1 using 
0.1 % TFA as solvent A and 80 % acetonitrile containing 
0.1 % TFA as solvent B. The gradient was 0–80 % of sol-
vent B for 55 min. Proteins were detected by monitoring 
the absorbance at 220  nm. The N-terminal amino acid 
sequences of both the large and small isolated chains 
were obtained on a Shimadzu PPSQ-33 automated pro-
tein sequencer. PTH amino acids were detected after sep-
aration on a reverse-phase C18 column under isocratic 
conditions, following the manufacturer’s instructions. 
The polypeptide sequences obtained were aligned auto-
matically with a BLAST search. The allergenic properties 
of each isolated chain were investigated by a mast-cell 
degranulation assay as described below.
Animals and antiserum
Animals and production of polyclonal antibodies
Isogenic female R/A Tor rats 70 days old weighing 150 g, 
considered to be good producers of IgE, were obtained 
from the animal house of the Universidade Federal Flu-
minense, Niteroi, RJ, and all experimental procedures 
were approved by the animal research ethics committee 
(Protocol 112).
Jat c 1 (10 mg) in 500 µL of sterile 0.01 M phosphate-
buffered saline (PBS) was emulsified with an equal vol-
ume of an adjuvant containing 5 mg of Al2OH3 and 5 mg 
of nigrosin. This mixture was injected into the four foot 
pads of the animals (250  µL/foot pad). Five rats were 
anesthetized after 15 days and bled by cardiac puncture, 
and the titer was determined by indirect competitive 
ELISA. The sera were pooled, lyophilized and stored at 
−20 °C until used in the mast-cell degranulation assay.
ELISA: monitoring antibody production
Microtiter-plate wells were each coated with 100  µL of 
1 mg/mL Jat c 1 in 0.2 M sodium carbonate buffer, pH 
9.6, and incubated for 18  h at 37  °C. The subsequent 
steps were performed at 37  °C. A microtiter plate was 
washed twice with PBS containing 0.05  % TWEEN 20 
(300  µL/well for 1  h), 300 µL of blocking buffer (1  % 
gelatin in PBS containing TWEEN 20) were added to 
each well and the plate was incubated for 1 h. The plate 
was again washed with PBS containing 0.05 % TWEEN 
(300  µL/well for 1  h). After coating with Jat c c1, each 
well received 50  µL of antiserum diluted 1:500 in PBS 
containing 0.05  % TWEEN 20. IgE was detected by a 
1:2000 dilution of goat anti-rat immunoglobulin (anti 
IgE) conjugated to peroxidase (Sigma) developed in 50 
µL of a solution containing 10 mg OPD, 10 µL of 30 % 
H2O2, 6.5 ml of 0.1 M citric acid, 7.0 ml of 0.2 M sodium 
phosphate and 9.0 mL of distilled H2O. The reaction was 
stopped by adding 50  µL of H2SO4 per well. The plate 
was read at 492 nm.
Two blanks were included in the experiment. Blank 
1 contained protein and the development solution to 
detect any intrinsic peroxidase activity in the samples, 
and Blank 2 contained carbonate/bicarbonate buffer, 
antibody and the development solution.
Mast‑cell degranulation assay
Rat peritoneal mast cells
Wistar rats were bred at the animal house of the Univer-
sidade Estadual do Norte Fluminense. All experimen-
tal procedures were approved by the university’s animal 
research ethics board (Protocol 112).
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For obtaining peritoneal mast cells, three rats 
(250  ±  20  g) were individually euthanized with CO2. 
The abdomens were gently massaged for approximately 
90 s, and then an incision approximately 5 cm in length 
was cut in the peritoneal cavities, which were carefully 
opened. The cavities were washed prior to the injection of 
20 mL of DMEM (Gibco) containing 12 U/mL of heparin, 
as described by Deus-de-Oliveira et al. (2011). The fluid 
containing peritoneal cells was aspirated with a Pasteur 
pipette. The fluid from the first rat was used for wash-
ing the second, and so on, to enrich the content of the 
wash with mast cells. The final content of the collected 
peritoneal fluid, approximately 15 mL, was transferred to 
Petri plates and incubated for 30  min at 37  °C to sepa-
rate the mast cells from the macrophages. Two-thirds of 
the upper layer were then aspirated and discarded. The 
supernatant (approximately 4–5 mL) enriched with mast 
cells (~1.8 ×  105 mast cells/mL) was separated into ali-
quots of 100 µL in Eppendorf tubes.
Mast‑cell activation
The mast cells (100 µL) were incubated with 1 μL of R/A 
Tor rat pre-immune serum as a control or were initially 
sensitized for 1 h at 37 °C using 1 μL of anti-Jat c 1 poly-
clonal antibodies. After sensitization, the mast cells were 
washed twice with Dulbecco’s Modified Eagle Medium 
(DMEM) (Sigma) and were then incubated with 100 ng of 
synthetic peptides or 100 ng of native Jat c 1 or its isolated 
chains (100  ng) for 1  h at 37  °C. To evaluate the mast-
cell degranulation, we mixed and incubated an aliquot 
of 10 µL of the cell suspension, after the various incuba-
tions, for 15 min with 10 µL of an aqueous solution con-
taining 0.1 % toluidine blue, 10 % formaldehyde and 1 % 
acetic acid, pH 2.8. The intact and degranulated mast cells 
were counted in a Neubauer chamber. The four quadrants 
were microscopically viewed using Nomarski differential 
interference contrast with a Zeiss Axioplan optical micro-
scope. Untreated mast cells were also incubated as a nega-
tive control with the dye under the above conditions and 
were observed with the optical microscope. The counting 
of intact and degranulated cells allowed an assessment 
of the acquisition procedure. Each experiment was per-
formed in triplicate using mast cells from the same ani-
mals. Graphs of the results of the degranulation assays 
were constructed using GraphPad Prism.
The data obtained in the degranulation assays were 
analyzed by one-way ANOVAs and multiple compari-
sons using Tukey’s tests (P  <  0.001). This analysis was 
performed by GraphPad Prism.
Synthesis of peptides for identifying IgE‑binding regions
Twelve peptides, 9–24 AA residues in length and based 
on the sequence of Jat c 1, were synthesized for mapping 
and characterizing IgE-binding regions using the multi-
ple method of the 9-fluorenylmethoxycarbonyl (Fmoc) 
(Sigma) strategy (Ruiter et  al. 2006). The amino acid 
sequences of the synthetic peptides are presented in 
Additional file 1: Figure S1).
Each peptide was probed individually with mast cells 
sensitized with rat IgE serum (immunized with Jat c 1), and 
mast-cell degranulation was evaluated as described below. 
A peptide was considered to be an IgE-binding region at 
levels of mast-cell degranulation >40 % (Felix et al. 2008).
Identification of amino acids involved in IgE binding
We used two strategies to identify the amino acids that 
bind to IgE pre-fixed in mast-cells: chemical modification 
of native synthetic peptides with Woodward’s Reagent K 
(WRK), and substitution of strategic amino acid residues 
in the characterized IgE-binding-regions.
Modification with Woodward’s Reagent K
WRK (N-ethyl-5-phenylisoxazolium-3′-sulfonate) 
(Sigma) is a specific reagent for the modification of 
dicarboxylic amino acids. The methodology proposed by 
Dunn et al. (1974) was used with modifications described 
by Deus-de-Oliveira et al. (2011). Synthetic peptides were 
treated with 250  mM WRK and incubated at 35  °C for 
3 h. The chemical modification was evaluated by reverse-
phase HPLC and mass spectrometry. The allergenicity of 
the treated peptides was analyzed by mast-cell degranu-
lation assays as previously described.
Substitution of strategic amino acid residues
The AA sequences of the IgE-binding peptides of Jat c 1 
contained two or more dicarboxylic residues (glutamic 
acid or aspartic acid). We determined if these residues 
were critical in these epitopes by constructing a library 
of peptides substituting glutamic acid by leucine using 
the Fmoc strategy described above. All peptides were 
purified by C18 reverse-phase HPLC. The IgE binding of 
mutated peptides was analyzed by a mast-cell degranula-
tion assay as previously described.
Structural studies
IgE-epitope candidates were localized using JHg, mod-
eled by Nair et al. (2012). The model of the processed Jat 
c 1 was constructed with Swiss-PDB Viewer. The struc-
ture of Jat c 1 was also modeled after substitution of some 
residues of aspartic acid and glutamic acid by leucine 
using the same program, and this structure was evaluated 
by PROCHECK.
Results
We purified and fully characterized Jat c 1, a known aller-
genic protein from J. curcas seeds. We also identified IgE 
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binding-regions of Jat c 1 and searched for homologous 
sequences in allergenic proteins from other plants that 
trigger allergenic cross-reactions.
Isolation and characterization of Jat c 1
The 2S albumin fraction from J. curcas seeds was 
obtained by saline extraction and chromatography on 
Sephadex G-50. Jat c 1 was then isolated by reverse-
phase chromatography, as previously reported (Maciel 
et al. 2009). Mass spectrometry identified two proteins of 
10.254 and 10.742 kDa (Fig. 1).
After the reduction and pyridylethylation of Jat 
c 1 (10.742  kDa), two polypeptide chains were iso-
lated by reverse-phase chromatography on a C18 col-
umn (Fig.  2b). The UV spectra of both chains peaked 
at 254  nm, indicating the production of a pyridylethyl 
cysteine after the reduction and alkylation (Fig. 2b insets 
S and L).
The N-terminal sequences of the first (small chain) 
and second (large chain) Jac c 1 peaks were VRDICKKE-
AERRVLSSCENTITQRRGRSE and PRQQVPRQCCN-
QAKELSAICRCESIHYLLEKQ, respectively. Alignment 
and analysis of these sequences were obtained from the 
Jatropha Genome Database (http://www.kazusa.or.jp/jat-
ropha/). The small chain aligned at position 33–61, and 
the large chain (N-terminal partial sequence) aligned at 
position 72–103. The molecular weight determined by 
mass spectrometry suggested that the large chain contin-
ued to position 133 (Fig. 3).
Investigation of continuous epitopes
Mast cells sensitized with rat-serum IgE and subse-
quently challenged with native Jat c 1 (+control) showed 
approximately 60 % degranulation. Mast cells challenged 
with isolated Jat c 1 polypeptide chains produced similar 
results. The small and large chains produced 58 and 64 % 
degranulation, respectively, indicating the presence of 
continuous IgE epitopes in both chains (Fig. 4).
We previously reported cross-reactivities of Jat c 1 
with allergens from R. communis using a passive cutane-
ous anaphylaxis assay (Maciel et  al. 2009). We corrobo-
rated this finding using ELISA assays with the native Jat 
c 1 (Fig.  5). Because the full sequence of Jat c 1 is now 
known, we performed a BLAST search to find the degree 
of homology of the large and small chains of Jat c 1 to R. 
communis allergens (Fig.  6). All cysteines and nearly all 
glutamic acid residues were conserved between Jat c 1 
and the R. communis allergens.
Identification of continuous IgE‑binding regions
Twelve peptides spanning the entire Jat c 1 sequence were 
synthesized for investigating the regions correspond-
ing to continuous epitopes (Additional file 1: Figure S1). 
All synthesized peptides were purified by reverse-phase 
HPLC (data not shown). Mast cells incubated with pre-
immune rat serum and synthetic peptides did not degran-
ulate, indicating that the serum did not recognize any of 
the synthesized peptides. The peptides P1, P4, P5, P6 and 
P8 spanning the length of the small and large chains of 
Fig. 1 Mass spectrum of Jat c 1, an allergenic protein from Jatropha curcas. Molecular weight of native Jat c 1 measured on Synapt G2 SI
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Jat c 1 were recognized by mast cells sensitized with rat-
serum IgE. Mast-cell degranulation was well above 40 % 
(Table  1). In contrast, mast-cell degranulation was not 
induced by P2, P3, P7 and peptides P9 to P13, under the 
same conditions (mast-cell degranulation <40 %).
Characterization of the critical amino acids in the 
continuous IgE‑binding regions
All of the identified continuous Jat c 1 IgE-binding 
peptides(P1, P4, P5, P6 and P8) contained at least two 
glutamic acid residues. To verify the possible involve-
ment of these residues in IgE binding, we treated P3 and 
the synthetic peptides that degranulated mast cells in the 
previous experiment (P1, P4, P5, P6 and P8) with WRK, 
a reagent known to modify glutamic acid. After WRK 
treatment, all peptides except P4 exhibited reduced mast-
cell degranulation, with levels similar to those of the neg-





























Fig. 2 Reversed-phase chromatographic isolation of polypeptide 
chains from Jat c 1. Jat c 1 was treated with guanidine chloride, DTT 
and vinyl pyridine and was fractionated on a C18 column. a Blank 
reaction. b Elution profile of the Jat c 1 polypeptide chains after 
denaturation. Peak S (small chain) and Peak L (large chain). Elution 
conditions: solvent A, 0.1 % TFA; solvent B, 80 % acetonitrile/0.1 % 
TFA. The elution profile was monitored at 220 nm, and the oblique line 
represents the acetonitrile gradient. Insets in b. Spectra of Jat c 1 small 
(S) and large (L) chains
Fig. 3 BLAST alignment of the N-terminal sequence of Jat c 1 with 
the NCBI GenBank database. Both chains aligned with hypothetical 
protein JCGZ_00819 from Jatropha curcas at positions 33–61 for the 
small chain (red) and 72–103 for the N-terminal partial sequence of 
the large chain (green). The linked peptide (62–71) is in gray. Based on 
the molecular weight determined by mass spectrometry, the large 
chain continued to position 133. The symbol “slash” indicates possible 
regions of precursor processing
Fig. 4 Mast-cell degranulation assay. +Control: mast cells sensitized 
by Jat c 1 antiserum and incubated with Jat c 1; −Control: mast cells 
incubated with DMEM; large chain, small chain: mast cells sensitized 
by Jat c 1 antiserum and incubated with the large or small chain, 
respectively, isolated from Jat c 1 under denaturation, reduction and 
alkylation conditions. Mean values from 5 experiments ± SD are 
presented. Statistical analysis was performed using one-way ANOVA 
followed by Turkey’s test. *p < 0.001
Fig. 5 ELISA for IgE anti-Jat c 1 antibodies. Sera from rats immunized 
with Jat c 1 were assayed for Jat c 1 (control) and allergens from R. 
communis. Blanks 1, 2 and 3 contained water, PBS and pre-immune 
serum, respectively. IgE anti-Jat c 1 recognized a mixture of Ric c 1 
and Ric c 3. Mean values from 5 experiments ± SD are presented. 
Statistical analysis was performed using one-way ANOVA followed by 
Turkey’s test. *p < 0.001
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by P4 was 42 %, a value near a negative mast-cell degran-
ulation reported by Deus-de-Oliveira et al. (2011).
To confirm the critical role of glutamic acid in IgE 
binding, we synthesized a series of related peptides sub-
stituting the strategic glutamic acid residues by leucine. 
The IgE-binding abilities of these modified peptides were 
evaluated by mast-cell degranulation assays. The sub-
stitution of glutamic acid residues by leucine in P5, P6 
and P8 significantly reduced mast-cell degranulation to 
approximately 30  %. Substitution of glutamic acid resi-
dues in P1 and P4 decreased mast-cell degranulation to 
40 %, similar to that of the negative control (Table 1).
Structural localization of continuous IgE‑binding epitopes
We then localized the identified continuous IgE epitopes 
(P1, P4, P5, P6 and P8)  within the three-dimensional 
structure of J. curcas hemagglutinin (JcCA0234191), a 
protein homologous to Jat c 1, that was modeled by Nair 
et al. (2012). P5 and P8 were the most exposed (Fig. 7).
Sequence alignment and investigation of cross‑reactivity 
between allergens from R. communis and J. curcas
Because Jat c 1 cross-reacted with allergens from R. 
communis (Maciel et  al. 2009), and because R. commu-
nis allergens can cross-react with allergens from wheat, 
soybean, peanuts, sesame, gluten and shrimp (Deus-de-
Oliveira et  al. 2011), we performed a BLAST search of 
the Jat c 1 large chain with allergen proteins from these 
food sources. The distribution of cysteine and dicarbo-
xylic residues (glutamic or aspartic acids) was highly 
conserved in these allergens, particularly the section cor-
responding to P5 (Fig. 6).
Discussion
 We previously reported the purification of an allergenic 
protein from J. curcas, Jat c 1, belonging to the 2S albu-
min family and the prolamin superfamily (Maciel et  al. 
2009). The cupin and prolamin superfamilies are the 
most widespread groups of plant proteins that contain 
Fig. 6 Multiple protein alignment. Query: Jat c 1 large chain; AGL07772—Chain A, 0.19 alpha-amylase inhibitor from wheat [Triticum aestivum]; 
NP001235693—napin-type 2S albumin 1 precursor from soybean [Glycine max] 3OB4_A Chain A, Ara H 2 major allergen from peanut [Arachis 
hypogaea]; ABB60053—2S albumin precursor isoform 3 from sesame [Sesamum indicum]; ADG45760 avenin-like b from gluten [Triticum aestivum]. 
Some determinant cysteine and glutamic and aspartic acid residues are highlighted in bold
Table 1 Mast cell degranulation induced by synthetic peptide




Mast cell degranulation Mast cell degranulation 
by WRK‑treated peptide
Amino acid sequences 
of the peptide were 
replaced acids glutamic 
by leucine
Mast cell degranulation 
by Glu → Leu peptide
Mast cell isolation (negative 
control)
21.60 ± 6.74 21.60 ± 6.74 – 21.60 ± 6.74
2S albumin (positive control) 65.13 ± 8.5 65.13 ± 8.5 – 65.13 ± 8.5
P1/VRDICKKEAERRDLS 59.21 ± 6.51 29.76 ± 3.66 VRLICKKLALRRDLS 43.95 ± 1.48
P4/QAKELSAICRCESIHYL 69.08 ± 3.63 42.35 ± 0.49 QAKLLSAICRCESIHYL 38.96 ± 1.86
P5/LEKQLEEGEVGS 71.46 ± 1.41 19.72 ± 1.23 LLKQLEEGLVGS 25.65 ± 5.44
P6/VGSEDEARRRTKNII 66.84 ± 9.76 22.05 ± 1.48 VGSLDLARRRTKNII 32.36 ± 0.50
P8/SEDMLAMPGIEN 60.95 ± 9.50 30.79 ± 1.11 SLLMLAMPGIEN 33.17 ± 0.23
P3/PRQQVPRQCCNQAKEL 35.08 ± 4.34 24.97 ± 5.17 PRQQVPRQCCN
P2/SCENYITQRRGR 24.20 ± 2.30 –
P7/DVCFGSICPR 32.06 ± 3.30 –
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allergens (Breiteneder and Radauer 2004). We purified 
and fully characterized this allergen to better understand 
the allergenic properties of Jat c 1 and the cross-reactivity 
of this protein with other allergens. We also identified IgE 
biding-regions and searched for homologous IgE-binding 
peptides in allergenic proteins from other foods allergens.
We previously determined the apparent molecular 
weight of Jat c 1 by SDS-PAGE and described the par-
tial sequence of the N-terminus of this protein (Maciel 
et al. 2009). The full sequence of Jat c 1 presented in the 
present study contained slight differences at the initial 
N-terminal region from the originally isolated allergen, 
probably because the seeds in the two studies were from 
different varieties of J. curcas. The isolated fraction was 
subjected to mass spectrometry, which indicated the 
presence of two proteins of 10.254 and 10.742 kDa.
A hemagglutinin isolated from J. curcas, JHg (Nair et al. 
2012), is homologous to Jat c 1. These authors speculated 
that JHg would thus probably have allergenic proper-
ties. They proposed a role for the carbohydrate moiety 
in this allergenic activity. Another homologous protein, 
JcT-I, MW 10.252  kDa isolated by Costa et  al. (2014), 
is a glycoprotein with an antibacterial effect due to its 
trypsin inhibitory activity. Alignment of Jat c 1 with JHg 
and JcT-I indicated that they had the same canonical 
sequence, so they could be considered “proteoforms”, a 
term suggested by Smith and Kelleher (2013) to desig-
nate all molecular forms of protein products of a single 
gene, including changes due to genetic variations, alter-
natively spliced RNA transcripts and post-translational 
modifications.
The allergic reaction mediated by Jat c 1 is a type I 
hypersensitivity, with the reaction due to IgE (Maciel 
et  al. 2009). IgE-binding epitopes can be classified into 
discontinuous (conformational) and continuous (sequen-
tial) epitopes (Odorico and Pellequer 2003). Conforma-
tional IgE epitopes can be destroyed by fragmentation, 
truncation or reassembly of the molecules, and sequen-
tial epitopes are resistant to degradation, even under 
denaturation, reduction and alkylation conditions (Odor-
ico and Pellequer 2003). To detect continuous epitopes 
in Jat c 1, we separated the polypeptide chains of this 
allergen using guanidine hydrochloride and DTT. Mast-
cell degranulation assays using the two denatured and 
isolated Jat c 1 polypeptide chains indicated the pres-
ence of continuous IgE epitopes in both the small and 
large chains (Fig. 4). Allergens belonging to the prolamin 
superfamily, including 2S albumin seed storage proteins, 
nonspecific lipid-transfer proteins and cereal α-amylase 
and protease inhibitors, are present in several important 
types of allergens of legumes, tree nuts, cereals, fruits 
and vegetables. These allergens have related structures 
and are stable under thermal processing and proteolysis, 
whereas other allergens, including tree pollinosis-associ-
ated food allergens such as the Bet v 1 family, have low 
stabilities under the same conditions (Breiteneder and 
Radauer 2004).
Mast-cell degranulation induced by synthetic peptides 
allowed us to identify potential sequential IgE-binding 
regions in Jat c 1. The twelve peptides spanning the full 
sequences of both the small and large chains of Jat c 1 
were incubated with mast cells previously activated with 
rat-serum IgE. P1, P4, P5, P6 and P8 promoted high lev-
els of mast-cell degranulation. Interestingly, all of these 
potential Jat c 1 IgE epitopes contained at least two glu-
tamic acid residues. Experiments with WRK, which mod-
ifies glutamic acid, and with a series of related peptides in 
which strategic glutamic acid residues were substituted 
by leucine, indicated the importance of carboxylic groups 
in IgE binding and consequently in mast-cell degranu-
lation. The involvement of glutamic acid in IgE binding 
was also observed by Denery-Papini et  al. (2012), who 
described a major role of gluten proteins (gliadins and 
glutenin subunits) in bread making. Their amino acid 
sequences were unusual, because they contained a high 
amount of proline (about 30  %) and glutamine (about 
40 %) and repetitive sequences. The peptide QPQQPFPQ 
was one of the repetitive sequences. The substitution of 
two or three glutamines in this epitope by glutamic acid 
at positions Q3 or Q4 and Q8 (QPEEPFPE) increased its 
recognition the most, indicating the importance of glu-
tamic acid in IgE recognition. We used the 3D structure 
of JHg to localize the potential IgE epitopes of Jat c 1. 
Potential IgE-binding peptides were located, and P5 and 
P8, which formed random loops, were the most exposed. 
These two peptides were consequently deemed to be 
good candidates for IgE interaction, which occurs when 
mast cells are exposed to native Jat c 1 protein. The struc-
ture of JHg was modeled by Nair et al. (2012), who used 
as a template Ric c 3, a major allergen from R. communis, 
Fig. 7 Mapping of the peptides onto a model of the three-dimen-
sional structure of Jat c 1. The structures of IgE-binding peptides are 
highlighted and located in the Jat c 1 structure
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which was modeled by Pantoja-Uceda et  al. (2003). JHg 
and Ric c 3 are formed by two polypeptide chains linked 
by disulfide bonds, but their 3D structures were modeled 
as single polypeptides containing the link peptide that is 
released by enzymatic cleavage during processing of the 
2S albumin precursor. Analysis of the structure of the Jat 
c 1 precursor, deduced from its DNA sequence, strongly 
suggests that this precursor is also cleaved after aspara-
gine residues (Fig. 3), similar to the processing of R. com-
munis precursor allergens (Irwin et al. 1990). Because P8 
would be removed during posttranslational processing, 
we thus concluded that P5 is a very important region for 
the stimulation of allergic responses to Jat c 1.
A BLAST search with the Jat c 1 protein sequence 
found a high degree of homology with R. communis aller-
gens, including total conservation of all eight cysteines 
and nearly all glutamic acid residues. A BLAST search 
with the sequence of the Jat c 1 large chain found a lower 
degree of homology with food allergens. The pattern of 
cysteine residues, however, remained conserved, and 
this chain contained at least two glutamic acid residues, 
notably in the section corresponding to P5. The folding 
pattern allowed by the positioning of the cysteine resi-
dues in the Jat c 1 sequence probably contributes to the 
exposure of the glutamic acid residues, similar to that 
observed in the R. communis allergen. This folding pat-
tern is consistent with the cross-reactivity between Jat 
c 1 and R. communis allergens observed by Maciel et al. 
(2009). Deus-de-Oliveira et  al. (2011) reported cross-
reactivity between R. communis allergens and wheat, 
peanut, sesame and gluten allergens. We also found 
structural homologies between Jat c 1 and these same 
food allergens and cross-reactivity between Jat c 1 and R. 
communis allergens, so we suggest that Jat c 1 will prob-
ably produce an allergenic cross-reaction with these food 
allergens.
The production of a vaccine against jatropha aller-
gens would be a good strategy for the proper handling 
of this plant. Our identification of potential IgE binding 
epitopes can thus contribute to the development of aller-
gen-specific immunotherapies (ASIT). Indeed, know-
ing the identity of IgE-binding epitopes is essential for 
the synthesis of hypoallergens employed in the develop-
ment of such vaccines. Our evidence suggests that, in the 
case of Jat c 1, the potential IgE-binding epitopes should 
have their glutamic acid residues substituted by leucine 
to produce a hypoallergenic protein. The production of 
minitopes (peptides that block IgE but do not trigger an 
allergic reaction) from modified Jat c 1 IgE-binding pep-
tides, where the strategic glutamic acid residues could be 
replaced by leucine residues, is a further ASIT possibil-
ity. A similar approach, the modification of critical amino 
acids in the epitope, was used successfully for the major 
birch pollen allergen Bet v 1 (Valenta and Niederberger 
2007). Finally, the production of vaccines containing “car-
rier-bound B-cell epitope-containing peptides” is another 
ASIT strategy Focke-Tejkl et al. (2015). The potential IgE-
binding epitopes also can be coupled with viral proteins 
to prevent an allergic reaction (Chen et al. 2012). Focke-
Tejkl et al. (2015) used this approach with Bet v 1 by fus-
ing two nonallergenic peptides and coupling them with 
the surface protein of hepatitis B. The above strategies are 
exciting new frontiers to be explored in the future by our 
group and other researchers worldwide.
Conclusion
In this study an allergenic protein from Jatropha curcas, 
Jat c1 was characterized. The IgE-binding peptides and 
the critical amino acids involved in mast cells degranu-
lation and histamine release were also identified. Since 
characterization of allergen/IgE-binding is a fundamental 
step to produce proteins mutant hypoallergenic and vac-
cine based on peptides, our study contribute to improved 
efficacy/safety profiles for safer allergy vaccination.
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